PRWeb The Leader Press Release Distribution
See How PRWeb Works

We're here to help 1-866-640-6397

Login Create Free Account


All Press Releases for February 3, 2009 Subscribe to this News Feed    Subscribe to this Podcast Feed
 

Juva Skin Banishes Bumps with New UniForm Cellulite Therapy Handpiece

Juva Skin and Laser Center continues to smooth out the bumps in aesthetic skin care with its latest offering. The New York-based cosmetic treatment center has introduced to its arsenal the UniForm handpiece, recently approved by the FDA for cellulite treatment.

(PRWEB) February 3, 2009 -- For those seeking painless cellulite treatment, New York City based Juva Skin and Laser Center is again leading the way in innovation. The popular aesthetic laser center is offering the new UniForm radiofrequency technology, recently approved by the FDA as a safe, effective treatment for cellulite.

The latest innovation in treatment for cellulite is available at Juva Skin.
The latest innovation in treatment for cellulite is available at Juva Skin.

The UniForm radiofrequency handpiece seamlessly melds radiofrequency and mechanical massage for an effective yet pain-free treatment.

"This is a unique approach to cellulite therapy," explains Bruce E. Katz, M.D., director of Juva Skin and Laser Center. "The combination of therapeutic heat with the mechanical application allows for deep penetration into the subcutaneous tissues for much better results."

UniForm was developed specifically for cellulite therapy. The radiofrequency provides gradual warming of subdermal tissues to therapeutic levels, while the mechanical massager stimulates circulation to subcutaneous tissues. The result is a dramatic reduction in the appearance of cellulite.

The UniForm treatment for cellulite was developed by Alma Lasers Ltd. The company is a leading producer of aesthetic devices that use light, laser and radiofrequency technologies in skin rejuvenation treatment. Alma Laser's innovations are generally developed for aesthetic uses, including laser wrinkle removal, laser lip and other skin rejuvenation treatment.

Treatment for cellulite using the UniForm system typically consists of six to eight sessions, lasting from 20 to 40 minutes each. For longer lasting results, patients can receive maintenance treatments every six months.

For more information about UniForm, or other services and products offered by Juva Skin and Laser Center, visit the Juva Skin Web site.

About Juva Skin and Laser Center:
New York City skin care leader Juva Skin and Laser Center specializes in state-of-the-art laser and cosmetic surgery, general dermatology and aesthetic skin care, including the newest innovations in laser skin treatments. Bruce E. Katz, M.D., a board certified dermatologist and director of Juva, oversees a team of skilled clinicians who treat a number of dermatological diseases, conditions and cosmetic imperfections with the latest New York City laser resurfacing equipment. In addition to its extensive laser surgery capabilities, AAAHC-accredited Juva Skin and Laser Center offers a medical spa and skin care products designed for home use.

###

Post Comment:
Trackback URL: http://www.prweb.com/pingpr.php/Q291cC1Qcm9mLVNxdWEtTG92ZS1GYWx1LVNpbmctWmVybw==

Technorati Tags

Bookmark -  Del.icio.us | Furl It | Technorati | Ask | MyWeb | Propeller | Live Bookmarks | Newsvine | TailRank | Reddit | Slashdot | Digg | Stumbleupon | Google Bookmarks | Sphere | Blink It | Spurl


Other Releases by this Member
OPTIONS
Printer Friendly Version
Download PDF Version
Download Reader Version
BlogThis
ShareThis
CONTACT INFORMATION
Angela Caponi
Juva Skin & Laser Center
212-688-5882+324
Email us Here
ATTACHED FILES

Dr. Bruce Katz

Dr. Bruce Katz
Juva Skin Director Dr. Katz uses the new UniForm device to administer safe cellulite therapy.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these release. Our complete disclaimer appears here.
 
Close Move